iLoF is an Oxford-based company, working to enable a new era of personalized medicine, by using AI and photonics to build a cloud-based library of diseases biomarkers and biological profiles. It is providing screening and stratification tools in an affordable, fast, portable way, saving up to 40% of cost and 70% of the time spent screening for clinical trials. Supported by leading institutions like Microsoft Ventures, Mayfied or the Oxford University, iLoF is currently focusing a validated platform technology in one of the biggest epidemics of our times: Alzheimer’s, while maintaining ongoing verticals on Digestive Cancer, Stroke and Infectious diseases.